0.1125USD-3.18%Mkt Cap: 107130 USDP/E: —Last update: 2026-06-01
Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to …
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap107.13K USD
Enterprise Value2.16M USD
Revenue (TTM)14.34K USD
Gross Profit268 USD
Net Income (TTM)-41.71M USD
Revenue/Share0.3710 USD
Last Price0.1125 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees26
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.01
PEG—
EV/EBITDA-0.12
EV/Revenue150.88
P/S6.67
P/B0.00
EPS (TTM)-1380.80
EPS (Forward)-11.29
52W Range
0.09110% of range53453.52
52W High53453.52 USD
52W Low0.0911 USD
Profitability
Gross Margin8.39%
Oper. Margin-35873.53%
EBITDA Margin0.00%
Profit Margin-1305608.79%
ROE-743.61%
ROA-252.56%
Growth
Revenue Growth1094.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.69M USD
CapEx (TTM)13.74K USD
FCF Margin-86049.34%
FCF Yield-11515.01%
Net Debt3.96M USD
Net Debt/EBITDA-0.22
Balance Sheet
Debt/Equity0.54
Current Ratio0.06
Quick Ratio0.02
Book Value/Sh368.06 USD
Cash/Share0.3300 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:27
Split DateMay 18, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.815.92K
Float798.09K
Insiders0.09%
Institutions0.22%
Short Interest
Short Ratio0.0d
Short % Float8.77%
Short % Out.8.77%
Shares Short3.39K
Short (prev mo.)5.48K
Technical
SMA 5011.26 (-99.0%)
SMA 2005645.53 (-100.0%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)2.88M
Avg Vol (10d)3.63M
Technical Indicators
RSI (14)13.0
MACD-4.4360
MACD Signal-5.6064
MACD Hist.+1.1704
BB Upper4.930 USD
BB Middle2.033 USD
BB Lower-0.8644 USD
BB Width285.04%
ATR (14)1.214 USD
Vol Ratio (20d)20.68x